Ifg Advisory, LLC Pfizer Inc Transaction History

Ifg Advisory, LLC

$1.75 Billion
Q4 2024

A detailed history of Ifg Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ifg Advisory, LLC holds 39,145 shares of PFE stock, worth $999,371. This represents 0.06% of its overall portfolio holdings.

Number of Shares

39,145

Previous 40,949 4.41%

Holding current value

$999,371

Previous $1.19 Million 12.41%

% of portfolio

0.06%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $44,739 - $54,462	-1,804 Reduced 4.41%	39,145 $1.04 Million
Q3 2024 Oct 30, 2024	BUY	$27.7 - $31.39 $76,562 - $86,761	2,764 Added 7.24%	40,949 $1.19 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $62,594 - $73,348	2,478 Added 6.94%	38,185 $1.07 Million
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $141,903 - $162,950	-5,481 Reduced 13.31%	35,707 $990,000
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $1.13 Million - $1.47 Million	-43,338 Reduced 51.27%	41,188 $1.19 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $7,220 - $8,439	225 Added 0.27%	84,526 $2.8 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $627,404 - $725,892	17,370 Added 25.95%	84,301 $3.09 Million
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $168,313 - $219,119	4,273 Added 6.82%	66,931 $2.73 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $455,910 - $595,140	-10,920 Reduced 14.84%	62,658 $3.21 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $686,638 - $838,213	15,691 Added 27.11%	73,578 $3.22 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $483,214 - $572,940	10,385 Added 21.86%	57,887 $3.03 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $218,639 - $270,921	4,779 Added 11.19%	47,502 $2.46 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $365,558 - $541,878	-8,847 Reduced 17.16%	42,723 $2.52 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $198,408 - $254,873	5,055 Added 10.87%	51,570 $2.22 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $367,790 - $416,644	10,242 Added 28.24%	46,515 $1.82 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $166,411 - $187,679	-4,969 Reduced 12.05%	36,273 $1.31 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $15,597 - $19,832	466 Added 1.14%	41,242 $1.52 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $25,685 - $30,135	809 Added 2.02%	40,776 $1.5 Million
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $2,530 - $3,069	84 Added 0.21%	39,967 $1.31 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $119,310 - $170,468	4,414 Added 12.44%	39,883 $1.3 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $159,662 - $181,196	-4,850 Reduced 12.03%	35,469 $1.39 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $15,172 - $19,674	-467 Reduced 1.15%	40,319 $1.45 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $167,112 - $187,628	4,519 Added 12.46%	40,786 $1.77 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $16,800 - $18,457	448 Added 1.25%	36,267 $1.54 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $102,830 - $117,237	-2,673 Reduced 6.94%	35,819 $1.56 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $20,233 - $24,542	-587 Reduced 1.5%	38,492 $1.7 Million
Q2 2018 Aug 02, 2018	BUY	$32.98 - $35.16 $41,159 - $43,879	1,248 Added 3.3%	39,079 $1.42 Million
Q1 2018 Apr 26, 2018	SELL	$31.91 - $37.02 $48,886 - $56,714	-1,532 Reduced 3.89%	37,831 $0
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $1.68 Million - $1.79 Million	-50,637 Reduced 56.26%	39,363 $1.43 Million
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $2.99 Million - $3.18 Million	90,000	90,000 $1.45 Million

Others Institutions Holding PFE

# of Institutions

3,329

Shares Held

3.68B

Call Options Held

101M

Put Options Held

131M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account